The nurse is preparing to administer digoxin (Lanoxin) to a client experiencing atrial fibrillation. Which of the following electrolyte imbalances would the nurse assess to reduce the incidence of toxicity with digoxin (Lanoxin)?
hypocalcemia
hypokalemia
hyperkalemia
hypernatremia
The Correct Answer is B
A. Hypocalcemia is not directly linked to digoxin toxicity; rather, it is more associated with calcium channel blockers.
B. Hypokalemia increases the risk of digoxin toxicity, as low potassium levels can enhance the effects of digoxin on the heart.
C. Hyperkalemia is not directly associated with toxicity; however, it can cause complications in patients taking digoxin.
D. Hypernatremia does not have a direct impact on digoxin toxicity; monitoring potassium levels is more critical.
Free Nursing Test Bank
- Free Pharmacology Quiz 1
- Free Medical-Surgical Quiz 2
- Free Fundamentals Quiz 3
- Free Maternal-Newborn Quiz 4
- Free Anatomy and Physiology Quiz 5
- Free Obstetrics and Pediatrics Quiz 6
- Free Fluid and Electrolytes Quiz 7
- Free Community Health Quiz 8
- Free Promoting Health across the Lifespan Quiz 9
- Free Multidimensional Care Quiz 10
View Related questions
Correct Answer is B
Explanation
A. Hypocalcemia is not directly linked to digoxin toxicity; rather, it is more associated with calcium channel blockers.
B. Hypokalemia increases the risk of digoxin toxicity, as low potassium levels can enhance the effects of digoxin on the heart.
C. Hyperkalemia is not directly associated with toxicity; however, it can cause complications in patients taking digoxin.
D. Hypernatremia does not have a direct impact on digoxin toxicity; monitoring potassium levels is more critical.
Correct Answer is D
Explanation
A. While aspirin has anti-inflammatory properties, this is not the primary reason it is prescribed after an MI.
B. Aspirin does not primarily function as an anti-pyretic in this context; its use is focused on cardiovascular benefits.
C. Aspirin does not have antiemetic properties and is not indicated for nausea control.
D. Inhibiting platelet aggregation is the key therapeutic effect of aspirin in preventing further clot formation, which is critical following an MI to reduce the risk of subsequent cardiovascular events.